As shown in Figure 2C, the ATF3 levels in vWAT were increased by 65.6% in OB+CRC patients compared with those in NW+CRC patients; however, no statistically significant difference was detected (P = 0.08). Here, ATF3 is linked to colorectal carcinoma.